Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

APLT

Applied Therapeutics Inc

Sep 20 • 04:00PM ET

7.70

Dollar change -0.30
Percentage change -3.75	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: SURI IWM VTI VXF IWO IWN VTWO IWC VFMO ITOT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.32	Insider Own	25.12%	Shs Outstand	114.85M	Perf Week	57.46%
Market Cap	884.34M	Forward P/E	-	EPS next Y	-0.42	Insider Trans	-4.04%	Shs Float	86.00M	Perf Month	23.79%
Income	-96.51M	PEG	-	EPS next Q	-0.16	Inst Own	79.94%	Short Float	11.36%	Perf Quarter	69.23%
Sales	10.66M	P/S	82.96	EPS this Y	32.73%	Inst Trans	-5.84%	Short Ratio	4.44	Perf Half Y	12.82%
Book/sh	0.63	P/B	12.22	EPS next Y	56.25%	ROA	-189.48%	Short Interest	9.77M	Perf Year	188.39%
Cash/sh	1.06	P/C	7.24	EPS next 5Y	-	ROE	-682.16%	52W Range	1.79 - 9.39	Perf YTD	129.85%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-8.72%	ROI	-133.26%	52W High	-18.00%	Beta	2.03
Dividend TTM	-	Quick Ratio	2.30	Sales past 5Y	0.00%	Gross Margin	95.68%	52W Low	330.17%	ATR (14)	0.72
Dividend Ex-Date	-	Current Ratio	2.30	EPS Y/Y TTM	59.67%	Oper. Margin	-586.31%	RSI (14)	67.52	Volatility	13.62% 9.70%
Employees	25	Debt/Eq	0.00	Sales Y/Y TTM	-	Profit Margin	-905.38%	Recom	1.17	Target Price	12.80
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	27.63%	Payout	-	Rel Volume	3.69	Prev Close	8.00
Sales Surprise	-94.24%	EPS Surprise	21.07%	Sales Q/Q	-98.65%	Earnings	Aug 07 BMO	Avg Volume	2.20M	Price	7.70
SMA20	32.34%	SMA50	34.06%	SMA200	62.49%	Trades		Volume	8,114,663	Change	-3.75%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-24	Initiated	William Blair	Outperform
Mar-26-24	Initiated	RBC Capital Mkts	Outperform	$12
Feb-22-24	Initiated	Leerink Partners	Outperform	$12
Jan-04-22	Downgrade	Barclays	Overweight → Equal Weight	$44 → $7
Aug-27-21	Downgrade	Goldman	Neutral → Sell	$16 → $10
Jun-25-21	Resumed	Goldman	Neutral	$18
Oct-08-20	Initiated	Truist	Buy	$85
Apr-22-20	Initiated	Goldman	Buy	$60
Feb-27-20	Initiated	Barclays	Overweight	$64
Jun-10-19	Initiated	Robert W. Baird	Outperform	$24
Jun-10-19	Initiated	Cowen	Outperform
Jun-10-19	Initiated	Citigroup	Buy	$29

Show Previous Ratings

Sep-18-24 10:56AM	Why Applied Therapeutics Stock Is Skyrocketing Today (Motley Fool) +68.82%
10:52AM	Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug (Benzinga)
07:00AM	Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia (GlobeNewswire)
Sep-04-24 07:00AM	Applied Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-07-24 07:00AM	Applied Therapeutics Reports Second Quarter 2024 Financial Results (GlobeNewswire)
02:37PM	Loading…
Jul-31-24 02:37PM	Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside (Benzinga) +19.28%
Jul-01-24 07:00AM	Applied Therapeutics Added to Russell 3000 Index (GlobeNewswire)
Jun-29-24 08:50PM	Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now? (Insider Monkey)
May-10-24 02:47PM	Applied Therapeutics Inc (APLT) Reports Q1 2024 Earnings: A Deep Dive into Financials and ... (GuruFocus.com)
May-09-24 01:55PM	APLT Stock Earnings: Applied Therapeutics Meets EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00AM	Applied Therapeutics Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-07-24 07:00AM	Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
Apr-15-24 07:00AM	Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer (GlobeNewswire)
Apr-04-24 07:00AM	Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024 (GlobeNewswire)
Mar-28-24 05:12PM	UPDATE 1-US FDA extends review of Applied Therapeutics' genetic disease drug (Reuters) -6.91%
04:42PM	Loading…
04:42PM	US FDA extends review of Applied Therapeutics' genetic disease drug (Reuters)
04:30PM	Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia (GlobeNewswire)
Mar-13-24 09:23AM	Applied Therapeutics (APLT) Surges 124% in a Month: Here's Why (Zacks)
Mar-08-24 04:32AM	Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress (GuruFocus.com)
Mar-06-24 07:00AM	Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results (GlobeNewswire)
Feb-28-24 01:01PM	FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder (Benzinga) +32.62%
09:48AM	Why Is Applied Therapeutics (APLT) Stock Up 59% Today? (InvestorPlace)
08:05AM	Applied Therapeutics Announces $100 Million Private Placement (GlobeNewswire)
08:00AM	Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia (GlobeNewswire)
Feb-21-24 09:21AM	13 Best Booming Stocks to Buy Right Now (Insider Monkey)
Feb-15-24 07:00AM	Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency (GlobeNewswire) +39.93%
Jan-05-24 09:23AM	Why Is Applied Therapeutics (APLT) Stock Down 30% Today? (InvestorPlace) -40.63%
03:31AM	Constellation Brands, Costco, Peloton rise premarket; Apple, Tesla fall (Investing.com)
02:32AM	Applied Therapeutics fails heart disease phase 3, seeks partner to bring molecule to market (FierceBiotech.com)
Jan-04-24 04:05PM	Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy (GlobeNewswire) +5.57%
07:00AM	Loading…
Jan-03-24 07:00AM	Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia (GlobeNewswire)
Nov-09-23 08:34AM	Applied Therapeutics Inc (APLT) Reports Q3 2023 Financial Results Amidst Upcoming Clinical ... (GuruFocus.com) -10.39%
07:30AM	Applied Therapeutics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 07:00AM	Applied Therapeutics to Present at the UBS Biopharma Conference 2023 (GlobeNewswire)
Nov-01-23 07:00AM	Applied Therapeutics to Host Diabetic Cardiomyopathy Expert Forum with Key Opinion Leaders on Tuesday, November 7 (GlobeNewswire)
Oct-20-23 01:22PM	12 Best Performing Biotech Stocks in 2023 (Insider Monkey)
Sep-28-23 07:00AM	Applied Therapeutics to Present Baseline Data from Phase 3 ARISE-HF Study Evaluating AT-001 at the 2023 EASD Annual Meeting (GlobeNewswire)
Sep-06-23 07:00AM	Applied Therapeutics Announces Successful Pre-NDA Meeting with the FDA and Confirms Plans to Submit NDA for Govorestat (AT-007) for Treatment of Classic Galactosemia to FDA in Q4 2023 (GlobeNewswire) +42.86%
Aug-11-23 07:42AM	We're A Little Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Rate (Simply Wall St.)
Aug-10-23 07:00AM	Applied Therapeutics Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-29-23 11:07AM	10 Stocks That Will Go Up 1000 Percent (Insider Monkey)
Jul-25-23 07:00AM	Applied Therapeutics Provides Regulatory Update on Galactosemia Program (GlobeNewswire) +6.38%
Jun-22-23 07:00AM	Applied Therapeutics to Present Baseline Data on the Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at the 2023 Annual Meeting of the American Diabetes Association (GlobeNewswire)
Jun-15-23 07:00AM	Applied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve Society (GlobeNewswire)
May-25-23 07:00AM	Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency (GlobeNewswire)
May-11-23 07:00AM	Applied Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-05-23 02:24PM	7 Hot Growth Stocks Poised to Triple in 2023 (InvestorPlace)
Apr-24-23 07:00AM	Applied Therapeutics, Inc. Announces $30 Million Private Placement of Equity (GlobeNewswire) +16.28%
07:00AM	Applied Therapeutics Announces Clinical Benefit of Govorestat (AT-007) in ACTION-Galactosemia Kids Trial; Company Plans to Meet with FDA Regarding Potential NDA Submission (GlobeNewswire)
Mar-23-23 06:30AM	Applied Therapeutics Reports Fourth Quarter and Year-end 2022 Financial Results (GlobeNewswire) -5.61%
Mar-18-23 09:54AM	Quite a few insiders invested in Applied Therapeutics, Inc. (NASDAQ:APLT) last year which is positive news for shareholders (Simply Wall St.)
Mar-01-23 07:00AM	Applied Therapeutics to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-16-23 10:46AM	Applied Therapeutics Reveals Pivotal Study Data In Hereditary Neuropathy (Benzinga) +17.00%
07:00AM	Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency (GlobeNewswire)
Feb-09-23 07:00AM	Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-04-23 06:00AM	Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe (GlobeNewswire) +15.28%
Nov-09-22 07:00AM	Applied Therapeutics Reports Third Quarter 2022 Financial Results (GlobeNewswire) -8.62%
Oct-31-22 07:00AM	Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022 (GlobeNewswire) +6.73%
Oct-25-22 07:00AM	Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy (GlobeNewswire) +6.91%
Oct-09-22 09:13AM	Insiders who purchased Applied Therapeutics, Inc. (NASDAQ:APLT) earlier this year lose an additional US$86k as the stock sinks to US$0.62 (Simply Wall St.)
Oct-06-22 11:18AM	Applied Therapeutics' Lead Candidate Pediatric Study Failed To Reach Statistical Significance (Benzinga) -33.47%
07:00AM	Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded Format (GlobeNewswire)
Sep-02-22 09:55AM	Bears are Losing Control Over Applied Therapeutics Inc. (APLT), Here's Why It's a 'Buy' Now (Zacks) -8.45%
Aug-12-22 07:00AM	Applied Therapeutics Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-28-22 07:00AM	Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference (GlobeNewswire)
Jun-22-22 10:12PM	Applied Therapeutics, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants (GlobeNewswire) -28.97%
04:10PM	Applied Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants (GlobeNewswire)
Jun-16-22 08:08AM	Companies Like Applied Therapeutics (NASDAQ:APLT) Could Be Quite Risky (Simply Wall St.) -9.49%
Jun-03-22 07:00AM	Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-007 for Treatment of Galactosemia (GlobeNewswire)
May-20-22 09:50AM	Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase (Zacks) -5.26%
May-19-22 07:00AM	Applied Therapeutics to Present at the UBS Global Healthcare Conference (GlobeNewswire)
May-18-22 11:47AM	Ultragenyx (RARE) Acquires Rights of AAV Gene Therapy Candidate (Zacks) -7.65%
11:03AM	Horizon (HZNP) Begins Enrollment in Alopecia Areata Study (Zacks)
May-17-22 11:31AM	Seagen's (SGEN) Stock Up on CEO's Resignation Announcement (Zacks)
May-13-22 10:30AM	Editas' (EDIT) EDIT-301 Gets Orphan Drug Tag for Beta Thalassemia (Zacks)
08:28AM	The Zacks Analyst Blog Highlights Angion Biomedica, Applied Therapeutics, Bolt Biotherapeutics, Ikena Oncology, and Landos Biopharma (Zacks)
May-12-22 06:59AM	Applied Therapeutics Reports First Quarter 2022 Financial Results (GlobeNewswire)
May-11-22 07:32AM	5 Biotech Stocks Set to Outpace Q1 Earnings Estimates (Zacks)
May-05-22 07:30AM	Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve Society (GlobeNewswire) -6.34%
May-03-22 10:47AM	What Awaits Meridian Bioscience (VIVO) This Earnings Season? (Zacks)
May-02-22 07:12AM	Great news for Applied Therapeutics, Inc. (NASDAQ:APLT): Insiders acquired stock in large numbers last year (Simply Wall St.)
Apr-28-22 10:24AM	Zosano (ZSAN) to Report Q1 Earnings: What's in the Cards? (Zacks)
Apr-12-22 11:47AM	Editas (EDIT) Begins Dosing Pediatric Patients in Gene Drug Study (Zacks) -7.76%
Apr-08-22 11:39AM	Aptinyx (APTX) Tanks as Neuropathic Pain Study Misses Goal (Zacks)
Apr-04-22 07:30AM	Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders (GlobeNewswire) +9.21%
Mar-31-22 11:05AM	Here's Why You Should Retain Universal Health (UHS) Stock Now (Zacks) -7.46%
Mar-22-22 11:36AM	Encompass Health's (EHC) Nationwide Hospital Count Rises to 147 (Zacks)
Mar-16-22 07:30AM	Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics (GlobeNewswire) +5.26%
Mar-15-22 12:19PM	Molina Healthcare (MOH) Up 32% in a Year: Is More Upside Left? (Zacks)
Mar-10-22 07:30AM	Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results (GlobeNewswire)
Mar-01-22 07:00AM	Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences (GlobeNewswire)
Feb-28-22 07:30AM	Applied Therapeutics Supports 15th Annual Rare Disease Day (GlobeNewswire) -5.53%
Feb-10-22 07:00AM	Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference (GlobeNewswire)
Jan-03-22 12:43PM	Why Applied Therapeutics Stock Is Sliding Today (Motley Fool) -30.50%
08:25AM	Applied Therapeutics To Hold Filing FDA Application For AT-007 In Rare Metabolic Disorder (Benzinga)
07:00AM	Applied Therapeutics Provides Regulatory Update on Galactosemia Program (GlobeNewswire)
03:14AM	Applied Therapeutics Tanks as Drug Candidate for Rare Disease Faces Delays (Investing.com)
Dec-16-21 07:00AM	Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD Deficiency (GlobeNewswire) -8.51%
Nov-18-21 07:00AM	Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism (GlobeNewswire) -11.18%
04:55AM	Great news for Applied Therapeutics, Inc. (NASDAQ:APLT): Insiders acquired stock in large numbers last year (Simply Wall St.)

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Funtleyder Leslie D.	Chief Financial Officer	Aug 22 '24	Sale	5.83	13,530	78,880	277,911	Aug 23 04:35 PM
Perfetti Riccardo	Chief Medical Officer	Aug 22 '24	Sale	5.83	22,681	132,230	986,853	Aug 23 04:33 PM
Shendelman Shoshana	President and CEO	Aug 13 '24	Sale	6.18	357,423	2,208,874	4,810,430	Aug 14 07:01 PM
Shendelman Shoshana	President and CEO	Aug 12 '24	Sale	5.98	300,000	1,794,000	5,167,853	Aug 14 07:01 PM
Shendelman Shoshana	President and CEO	Aug 14 '24	Sale	5.93	119,591	709,175	4,690,839	Aug 14 07:01 PM
Shendelman Shoshana	Officer	Aug 12 '24	Proposed Sale	6.21	1,000,000	6,210,000		Aug 09 08:43 PM
Shendelman Shoshana	President and CEO	Jun 06 '24	Sale	4.32	61,795	266,954	3,756,019	Jun 10 04:29 PM
Perfetti Riccardo	Chief Medical Officer	Jun 06 '24	Sale	4.32	22,003	95,053	1,009,534	Jun 10 04:28 PM
Funtleyder Leslie D.	Chief Financial Officer	Jun 06 '24	Sale	4.32	16,980	73,354	291,441	Jun 10 04:25 PM
ALEXANDRIA REAL ESTATE EQUITIE	10% Owner	Jun 05 '24	Sale	4.24	150,000	636,000	5,855,077	Jun 06 06:45 PM
ALEXANDRIA REAL ESTATE EQUITIE	10% Owner	Jun 04 '24	Sale	4.21	150,000	631,500	6,005,077	Jun 06 06:45 PM
Shendelman Shoshana	President and CEO	Mar 14 '24	Sale	5.39	318,573	1,717,108	3,817,814	Mar 18 06:12 PM
Perfetti Riccardo	Chief Medical Officer	Mar 14 '24	Sale	5.39	110,804	597,234	1,031,537	Mar 18 06:02 PM
Hansard Adam	Chief Commercial Officer	Mar 14 '24	Sale	5.39	48,871	263,415	732,919	Mar 18 06:00 PM
Funtleyder Leslie D.	Chief Financial Officer	Mar 14 '24	Sale	5.39	28,727	154,839	308,421	Mar 18 05:57 PM
Kanter Stacy J.	Director	Dec 01 '23	Buy	2.18	30,000	65,367	63,000	Dec 05 07:03 PM
Shendelman Shoshana	President and CEO	Nov 30 '23	Sale	1.97	3,968	7,817	2,596,387	Dec 01 07:42 PM
Perfetti Riccardo	Chief Medical Officer	Nov 30 '23	Sale	1.97	1,583	3,119	692,341	Dec 01 07:42 PM
Hansard Adam	Chief Commercial Officer	Nov 30 '23	Sale	1.97	965	1,901	381,790	Dec 01 07:42 PM
ALEXANDRIA REAL ESTATE EQUITIE	10% Owner	Nov 03 '23	Sale	2.31	143,450	331,370	5,580,077	Nov 06 04:56 PM
ALEXANDRIA REAL ESTATE EQUITIE	10% Owner	Nov 02 '23	Sale	2.32	103,808	240,835	5,723,527	Nov 06 04:56 PM
ALEXANDRIA REAL ESTATE EQUITIE	10% Owner	Nov 01 '23	Sale	2.36	172,742	407,671	5,827,335	Nov 02 04:44 PM
ALEXANDRIA REAL ESTATE EQUITIE	10% Owner	Oct 31 '23	Sale	2.41	155,000	373,550	6,000,077	Nov 02 04:44 PM
Shendelman Shoshana	President and CEO	Sep 27 '23	Sale	2.70	115,632	312,206	2,600,355	Sep 29 08:03 PM
Perfetti Riccardo	Chief Medical Officer	Sep 27 '23	Sale	2.70	10,932	29,516	693,924	Sep 29 08:02 PM
Hansard Adam	Chief Commercial Officer	Sep 27 '23	Sale	2.70	9,720	26,244	382,755	Sep 29 08:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APLT

Applied Therapeutics Inc

Upgrade your FINVIZ experience